EMA Application withdrawn: Epostim (epoetin alfa) — Reliance GeneMedix Plc

View source ↗

Summary

The EMA entry for Epostim (epoetin alfa) shows that the application was withdrawn by Reliance GeneMedix Plc for the anemia indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Epostim (erythropoietin)

Snippet

Status: Application withdrawn. Therapeutic area: Anemia. MAH: Reliance GeneMedix Plc. Decision date: 19/04/2011